Skip to main content
Table of Contents
Print

At what age can cystic fibrosis be diagnosed? 

Author: Harry Whitmore, Medical Student | Reviewed by: Dr. Rebecca Fernandez, MBBS

Cystic fibrosis is a genetic condition that is present from the moment of conception, meaning it can technically be diagnosed at any age, including before birth. However, in the United Kingdom, the vast majority of cases are now identified within the first few weeks of life thanks to the national newborn screening programme. While early diagnosis is the standard, some individuals with milder genetic mutations may not show significant symptoms until later in childhood or even well into adulthood. Regardless of the age at which a diagnosis is confirmed, the clinical goal remains the same: to initiate specialist multidisciplinary care as quickly as possible to preserve lung function and support nutritional health. 

What We’ll Discuss in This Article 

  • The standard age for diagnosis through newborn screening. 
  • The possibility of prenatal testing during pregnancy. 
  • Why some children are diagnosed in early childhood (pre-school age). 
  • Clinical signs that lead to a diagnosis in teenagers and adults. 
  • The impact of “mild” or “atypical” mutations on the age of detection. 
  • How the age of diagnosis has changed over the last two decades in the UK. 

Diagnosis in the first weeks of life 

For most babies born in the UK today, the diagnosis of cystic fibrosis occurs when they are between two and four weeks old. According to the NHS, the newborn blood spot test, also known as the heel prick test, is carried out when a baby is five days old. This screening test checks for a range of conditions, including cystic fibrosis. If the blood test suggests the condition, a confirmatory sweat test is usually performed before the baby is a month old. This early detection is a cornerstone of modern UK healthcare, as it allows treatment to begin before the baby becomes unwell, significantly improving their long-term health and growth prospects. 

Prenatal diagnosis during pregnancy 

In some cases, cystic fibrosis can be diagnosed before a baby is even born. This typically occurs if the parents already know they are carriers of the faulty gene or if they have previously had a child with the condition. NICE guidance states that prenatal testing, such as chorionic villus sampling (CVS) or amniocentesis, can be used to check the genetic makeup of the foetus. CVS is usually performed between weeks 11 and 14 of pregnancy, while amniocentesis is performed from week 15 onwards. While these tests are highly accurate, they are usually only offered to families with a known genetic risk rather than as a routine part of all pregnancies. 

Diagnosis in early childhood 

Before the introduction of universal newborn screening in the UK in 2007, many children were not diagnosed until they started showing physical symptoms. Even today, a small number of children may “slip through” the screening process if they have extremely rare mutations that are not included in the standard testing panel. In these cases, diagnosis usually happens between the ages of one and five. Parents may notice that their child has a persistent cough, frequent chest infections, or difficulty gaining weight despite having a healthy appetite. Another classic sign is “salty-tasting” skin, which parents often notice when kissing their child. 

Diagnosis in teenagers and adults 

It is possible to reach adulthood without knowing you have cystic fibrosis, particularly if you have a “mild” or “atypical” form of the condition. These individuals often have “residual function” mutations, where the CFTR protein works just well enough to prevent severe childhood illness but not well enough to keep the lungs and sinuses healthy over many decades. The NHS notes that adults may be diagnosed after presenting with recurring bouts of pneumonia, chronic sinusitis, or unexplained pancreatitis. In men, the condition is sometimes discovered during fertility investigations, as the genetic fault can cause a blockage in the tubes that carry sperm. 

The impact of “atypical” presentations 

The age of diagnosis is often linked to the specific class of genetic mutation an individual possesses. Those with Class I, II, or III mutations usually produce almost no functional CFTR protein and are almost always diagnosed at birth due to significant IRT levels in their blood. Conversely, those with Class IV or V mutations may produce enough functional protein to remain relatively healthy for years. These “atypical” cases may be diagnosed in their 20s, 30s, or even 40s. While these individuals may have had a milder course in childhood, they still require specialist care once diagnosed to prevent progressive lung damage or complications like cystic fibrosis-related diabetes. 

Age Group Common Method of Diagnosis Primary Symptoms / Triggers 
Newborn Blood spot (heel prick) test at 5 days. Routine screening (often asymptomatic). 
Infant Sweat test or genetic testing. Poor weight gain (failure to thrive), oily stools. 
Child Clinical referral to specialist. Persistent cough, frequent chest infections. 
Adult Specialist investigations. Bronchiectasis, male infertility, pancreatitis. 

Why the age of diagnosis matters 

The age at which a person is diagnosed has a direct impact on their long-term prognosis. In the past, when diagnosis was often delayed until a child was severely malnourished or had permanent lung scarring, life expectancy was significantly lower. Today, because the NHS identifies the vast majority of cases in the first month of life, children can start on pancreatic enzymes and daily physiotherapy immediately. This proactive approach prevents early lung damage and ensures that children reach their full growth potential. For those diagnosed as adults, the diagnosis often provides a long-awaited explanation for years of “mystery” respiratory or digestive issues, finally allowing them to access the correct treatments. 

Conclusion 

In the United Kingdom, the standard age of diagnosis for cystic fibrosis is within the first few weeks of life through the newborn screening programme. However, the condition can be identified at any age, from prenatal testing in the womb to diagnostic investigations in adulthood for those with milder mutations. Early diagnosis remains the gold standard, providing the best opportunity to manage symptoms effectively and support a high quality of life. 

If you experience severe, sudden, or worsening symptoms, call 999 immediately. 

Can a child “pass” the newborn screen but still have cystic fibrosis? 

Yes, in rare cases where a child has a very unusual mutation, the initial screening may be negative, but symptoms later in life will trigger a sweat test. 

What is the oldest someone has been diagnosed with cystic fibrosis? 

There are documented cases in the UK of individuals being diagnosed in their 60s and 70s, usually after lifelong struggles with chronic bronchiectasis. 

Does a later diagnosis mean the condition is less severe? 

Generally, yes; a diagnosis in adulthood usually suggests that the person has some “residual function” in their CFTR protein, leading to a slower progression. 

Is the sweat test accurate for people of all ages? 

Yes, the sweat test is considered the “gold standard” for diagnosis from roughly two weeks of age through to adulthood. 

Can I be tested for cystic fibrosis if I am pregnant? 

If you or the father are known carriers or have a family history, you can be offered prenatal testing to check the baby’s status. 

Why does the NHS screen at 5 days old? 

This timing allows for the accurate detection of various metabolic and genetic conditions while ensuring treatment can start as early as possible. 

What should I do if I suspect my older child has cystic fibrosis? 

You should speak to your GP about their symptoms; they can refer your child for a sweat test at a local hospital or specialist centre. 

Authority Snapshot (E-E-A-T Block) 

This article provides a medically accurate overview of the various ages at which cystic fibrosis can be diagnosed, specifically within the context of the UK healthcare system. The content is written by a professional medical content team and reviewed by Dr. Rebecca Fernandez, a UK-trained physician with experience in internal medicine, emergency care, and intensive care. All information is strictly aligned with the clinical pathways and screening standards established by the NHS and NICE. 

Harry Whitmore, Medical Student
Author
Dr. Rebecca Fernandez, MBBS
Reviewer

Dr. Rebecca Fernandez is a UK-trained physician with an MBBS and experience in general surgery, cardiology, internal medicine, gynecology, intensive care, and emergency medicine. She has managed critically ill patients, stabilised acute trauma cases, and provided comprehensive inpatient and outpatient care. In psychiatry, Dr. Fernandez has worked with psychotic, mood, anxiety, and substance use disorders, applying evidence-based approaches such as CBT, ACT, and mindfulness-based therapies. Her skills span patient assessment, treatment planning, and the integration of digital health solutions to support mental well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewer's privacy. 

Categories